Abstract: A drug delivery device configured to simultaneously interface with a scala tympani and a scala vestibuli of a cochlea, wherein the device can be configured to deliver drug to the cochlea at least in part via a post introduction non-diffusion based delivery, and wherein the device can be configured to induce complete circuit circulation from the scala tympani to the scala vestibuli and/or vice versa, thereby distributing drug within the cochlea.

Abstract: Disclosed examples generally include methods and apparatuses related to microphone units, such as may be found in implantable medical devices (e.g., cochlear implants). Microphone units generally include a microphone element connected to a chamber having a concave floor with the chamber covered by a membrane. Microphone units can be configured to produce an output based on pressure waves (e.g., sound waves) that reach the membrane. In an example, a microphone unit has a pressurized gas within the chamber below the membrane such that, while in a static state, the membrane deflects away from the chamber floor.

Abstract: Disclosed examples generally include methods and apparatuses related to microphone units, such as may be found in implantable medical devices (e.g., cochlear implants). Microphone units generally include a microphone element connected to a chamber having a concave floor with the chamber covered by a membrane. Microphone units can be configured to produce an output based on pressure waves (e.g., sound waves) that reach the membrane. In an example, a microphone unit has a pressurized gas within the chamber below the membrane such that, while in a static state, the membrane deflects away from the chamber floor.

Abstract: The disclosed technology includes an example system that has a request throttling manager that is configured to receive a first file data request, queue the first file data request in a first request queue, and process the first file data request based on the first token bucket. The first token bucket includes a sufficient first quantity of first tokens to process the first file data request. The system further includes a storage manager configured to access one or more storage nodes of a plurality of storage nodes of a distributed storage system in response to the first file data request.

Abstract: Disclosed examples generally include methods and apparatuses related to microphone units, such as may be found in implantable medical devices (e.g., cochlear implants). Microphone units generally include a microphone element connected to a chamber having a concave floor with the chamber covered by a membrane. Microphone units can be configured to produce an output based on pressure waves (e.g., sound waves) that reach the membrane. In an example, a microphone unit has a pressurized gas within the chamber below the membrane such that, while in a static state, the membrane deflects away from the chamber floor.

Abstract: A bone conduction device includes split high-frequency and low-frequency actuators. The frequency response of the low-frequency actuator can be restricted to the lower range of hearing frequencies to improve performance. The high-frequency actuator can be implanted under tissue close to the cochlea to improve transmission efficiency, since high-frequency vibrations suffer greater attenuation.

Abstract: The disclosed technology includes an example system that has a request throttling manager that is configured to receive a first file data request, queue the first file data request in a first request queue, and process the first file data request based on the first token bucket. The first token bucket includes a sufficient first quantity of first tokens to process the first file data request. The system further includes a storage manager configured to access one or more storage nodes of a plurality of storage nodes of a distributed storage system in response to the first file data request.

Abstract: An implantable component, such as by way of example, an implantable component of a transcutaneous bone conduction device, the implantable component comprising a piezoelectric transducer, wherein the implantable component is configured to temporarily prevent the piezoelectric transducer from moving inside the housing while the housing is implanted in the recipient.

Abstract: A bone conduction device includes split high-frequency and low-frequency actuators. The frequency response of the low-frequency actuator can be restricted to the lower range of hearing frequencies to improve performance. The high-frequency actuator can be implanted under tissue close to the cochlea to improve transmission efficiency, since high-frequency vibrations suffer greater attenuation.

Abstract: A bone conduction device includes split high-frequency and low-frequency actuators. The frequency response of the low-frequency actuator can be restricted to the lower range of hearing frequencies to improve performance. The high-frequency actuator can be implanted under tissue close to the cochlea to improve transmission efficiency, since high-frequency vibrations suffer greater attenuation.

Abstract: Disclosed examples generally include methods and apparatuses related to microphone units, such as may be found in implantable medical devices (e.g., cochlear implants). Microphone units generally include a microphone element connected to a chamber having a concave floor with the chamber covered by a membrane. Microphone units can be configured to produce an output based on pressure waves (e.g., sound waves) that reach the membrane. In an example, a microphone unit has a pressurized gas within the chamber below the membrane such that, while in a static state, the membrane deflects away from the chamber floor.

Abstract: A device including a cochlear implant electrode array and an apparatus configured to sense a phenomenon of fluid in a cochlea, wherein the apparatus and the electrode array are a single unit.

Abstract: A bone conduction device includes split high-frequency and low-frequency actuators. The frequency response of the low-frequency actuator can be restricted to the lower range of hearing frequencies to improve performance. The high-frequency actuator can be implanted under tissue close to the cochlea to improve transmission efficiency, since high-frequency vibrations suffer greater attenuation.

Abstract: Implantable components configured to be secured to a recipient with a bonding agent are presented herein. The implantable components are configured to be implanted adjacent to a recipient's bone and/or tissue and have a surface for attachment to the bonding agent.

Abstract: Implantable components configured to be secured to a recipient with a bonding agent are presented herein. The implantable components are configured to be implanted adjacent to a recipient's bone and/or tissue and have a surface for attachment to the bonding agent.